Adrianus Donders - EnteroMedics Sr. VP of Research and Advanced Devel.

SVP

Mr. Adrianus Donders is the Senior Vice President Research and Advanced Development of EnteroMedics Inc., since April 2005. From September 2003 to April 2005, Mr. Donders was Director Communication Systems Engineering for Medtronic USA. From June 2000 to August 2003, Mr. Donders served as Director Clinical Study Management and Research and Development Europe for Medtronic Europe since 2005.
Age 60
Tenure 19 years
Phone651-634-3003
Webhttp://www.enteromedics.com
Donders received a degree equivalent to a Master’s of Electrical Engineering from the Institute of Technology Eindhoven Netherlands.

EnteroMedics Management Efficiency

The company has return on total asset (ROA) of (48.42) % which means that it has lost $48.42 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (146.32) %, meaning that it created substantial loss on money invested by shareholders. EnteroMedics' management efficiency ratios could be used to measure how well EnteroMedics manages its routine affairs as well as how well it operates its assets and liabilities.
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. EnteroMedics (ETRM) is traded on NASDAQ Exchange in USA and employs 37 people.

Management Performance

EnteroMedics Leadership Team

Elected by the shareholders, the EnteroMedics' board of directors comprises two types of representatives: EnteroMedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EnteroMedics. The board's role is to monitor EnteroMedics' management team and ensure that shareholders' interests are well served. EnteroMedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EnteroMedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jon Tremmel, Consultant To The CEO and Director
Peter Delange, Senior Vice President - Operations and Business Development
Scott Youngstrom, CFO, Chief Compliance Officer
Dan Gladney, CEO and President and Director
Nicholas Teti, Independent Director
Carl Goldfischer, Independent Director
Catherine Friedman, Independent Director
Michael Mashaal, Director
Lori McDougal, Director
Gary Blackford, Director
Nick Ansari, Senior Vice President - Sales
Scott Shikora, Executive Vice President - Medical Affairs and Chief Medical Officer
Anthony Jansz, Director
Adrianus Donders, Sr. VP of Research and Advanced Devel.
Katherine Tweden, Co-Founder and VP of Clinical and Regulatory
Mark Knudson, Founder and Executive Chairman
Gregory Lea, CFO, Principal Accounting Officer, Chief Compliance Officer and Secretary
Paul Hickey, Senior Vice President - Marketing and Reimbursement
Bobby Griffin, Independent Director
Tonya Dowd, Vice President - Reimbursement
Naqeeb Ansari, Senior Vice President - Sales

EnteroMedics Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EnteroMedics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EnteroMedics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EnteroMedics' short interest history, or implied volatility extrapolated from EnteroMedics options trading.

Pair Trading with EnteroMedics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnteroMedics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnteroMedics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Life Storage could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Life Storage when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Life Storage - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Life Storage to buy it.
The correlation of Life Storage is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Life Storage moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Life Storage moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Life Storage can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in EnteroMedics Stock

If you are still planning to invest in EnteroMedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EnteroMedics' history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation